In 2023, almost 46 percent of adults in Alabama suffered from hypertension. This statistic depicts the rate of adults suffering from hypertension in the United States in 2023, sorted by state.

The prevalence of hypertension in the U.S. among men was 28.3 percent in 2023. At that time, around 26.7 percent of women in the U.S. had hypertension. The statistic illustrates the prevalence of hypertension in the U.S. from 2019 to 2023, by gender.

In 2023, it was estimated that around 58 percent of those aged 65 years and older in the United States had been diagnosed with hypertension. This statistic shows the percentage of U.S. adults aged 65 years and older who had ever been told by a doctor or other health professional they had hypertension from 2019 to 2023.

Hypertension is an important and modifiable risk factor for cardiovascular disease and mortality. Over the last decade, national-levels of controlled hypertension have increased, but little information on hypertension prevalence and trends in hypertension treatment and control exists at the county-level. We estimate trends in prevalence, awareness, treatment, and control of hypertension in US counties using data from the National Health and Nutrition Examination Survey (NHANES) in five two-year waves from 1999–2008 including 26,349 adults aged 30 years and older and from the Behavioral Risk Factor Surveillance System (BRFSS) from 1997–2009 including 1,283,722 adults aged 30 years and older. Hypertension was defined as systolic blood pressure (BP) of at least 140 mm Hg, self-reported use of antihypertensive treatment, or both. Hypertension control was defined as systolic BP less than 140 mm Hg. The median prevalence of total hypertension in 2009 was estimated at 37.6% (range: 26.5 to 54.4%) in men and 40.1% (range: 28.5 to 57.9%) in women. Within-state differences in the county prevalence of uncontrolled hypertension were as high as 7.8 percentage points in 2009. Awareness, treatment, and control was highest in the southeastern US, and increased between 2001 and 2009 on average. The median county-level control in men was 57.7% (range: 43.4 to 65.9%) and in women was 57.1% (range: 43.0 to 65.46%) in 2009, with highest rates in white men and black women. While control of hypertension is on the rise, prevalence of total hypertension continues to increase in the US. Concurrent increases in treatment and control of hypertension are promising, but efforts to decrease the prevalence of hypertension are needed.

BackgroundHypertension is the most common primary diagnosis associated with postpartum readmissions within 42 days of delivery hospitalization. In the United States, nearly half of the cases of eclampsia, a severe form of preeclampsia, develop during the postpartum period, and the postpartum onset of hypertensive disorders of pregnancy, like antepartum hypertension poses long-term health risks to pregnant individuals, including an increased likelihood of developing overall cardiovascular disease, coronary heart disease, heart failure, and chronic hypertension. In this paper, we estimate the trends in the incidence of readmissions for postpartum hypertension within 42 days of delivery discharge in the US, disaggregated by median household income.Methods and findingsUsing National Readmissions Database, we calculated the readmission rates for postpartum hypertension, both overall and stratified by ZIP Code median household income for each year between 2010 and 2019. We also calculated the percentage change and average annual growth rate (AAGR) in the rate of readmissions for postpartum hypertension between 2010 and 2019 for each income group. We then used a logistic regression model to compare the temporal changes in readmission for postpartum hypertension between the lowest and the highest income quartiles. The estimated incidence of postpartum hypertension readmissions doubled for all the income groups between 2010 and 2019 (0.36% vs. 0.8%). While the incidence of postpartum hypertension cases was higher among the lowest-income quartile, the increase in postpartum hypertension readmissions between 2010 and 2019 was greater in the highest-income quartile. Moreover, the incidence of postpartum hypertension readmissions rose faster in pregnant patients without a history of hypertension compared to those with a history of hypertension (AAGR 8.3% vs. 5.1%).ConclusionThe increasing postpartum hypertension readmission burden suggests rising future health risks among mothers and a growing cost burden to the U.S. healthcare system. The higher rate of increase in postpartum hypertension readmissions among people without a history of hypertension calls for blood pressure checking in the postpartum period for all patients regardless of risk status.

Percentage change and average annual change in the incidence and number of pregnant individuals readmitted for postpartum hypertension between 2010 and 2019, by hypertension status during index delivery hospitalization and ZIP income quartile.

Create maps of U.S. blood pressure medication nonadherence among Medicare Part D beneficiaries aged 65 and older, by county. Data can be stratified by race/ethnicity and blood pressure medication class. Blood pressure medication nonadherence is defined as a proportion of days a beneficiary was covered with blood pressure medication of <80%.Visit the CDC/DHDSP Atlas of Heart Disease and Stroke for additional data and maps. Atlas of Heart Disease and StrokeData Source and MethodologyAntihypertensive nonadherence, defined as a proportion of days a beneficiary was covered with antihypertensives of <80%, was assessed using prescription drug claims data among Medicare Advantage or Medicare fee-for-service beneficiaries aged ≥65 years with Medicare Part D coverage. Administrative data and prescription drug event data were accessed via the Centers for Medicare and Medicaid Services Chronic Conditions Data Warehouse. Analyses were stratified by antihypertensive class, beneficiaries’ state and county of residence, type of prescription drug plan, and treatment and demographic characteristics. Visit the Vital Signs Morbidity and Mortality Weekly Report for more detailed information.Data DictionaryData for counties with small populations are not displayed when a reliable rate could not be generated. These counties are represented in the data with values of '-1.' CDC/DHDSP excludes these values when classifying the data on a map, indicating those counties as 'Insufficient Data.' Data field names and descriptions   stcty_fips: state FIPS code + county FIPS code   county: county name   Blood pressure medication nonadherence percentage for Medicare Part D Beneficiaries aged 65 and older     htnadh_all: All beneficiaries     htnadh_aian: American Indian and Alaska Native, non-Hispanic beneficiaries     htnadh_api: Asian and Pacific Islander, non-Hispanic beneficiaries     htnadh_black: Black, non-Hispanic beneficiaries     htnadh_hisp: Hispanic beneficiaries     htnadh_white: White, non-Hispanic beneficiaries     diuradh: Diuretic nonadherence     rasadh: Renin-Angiotensin System nonadherenceMore Questions?Interactive Atlas of Heart Disease and StrokeData SourcesStatistical Methods

Introduction: The American Heart Association/American College of Cardiology has published In 2017 new guidelines for hypertension. These guidelines change the criteria to classify patients with hypertension. There has not been yet a study that analyzes the consequences of these changes in developing countries. The objective of our study was to characterize changes in the classification of hypertension with the new guidelines among Peruvian patients and to determine the factors associated with being newly-diagnosed hypertensive. Methods: An analytical cross-sectional investigation was carried out, which was based on the secondary analysis of the data of hypertension. We compare certain variable including using antihypertensive medication, region, and other sociodemographic characteristics. We performed a descriptive analysis of the variables shown as frequency and percentage. P values that were less than 0.05 were considered statistically significant, it were obtained using a multivariate analysis. Results: Of the 5615 patients in this cohort, with the old criteria, 4915 (87.5%) did not have the diagnosis of hypertension; however, with the new criteria, 1,415 (25%) will be diagnosed with hypertension with the new criteria. 467 (9%) of patients who were not taking medications and 85 (32%) of patients who were taking medications will switch from having high-normal blood pressure to grade 1 hypertension, with the new guideline. The recent diagnosis of hypertension was associated with sex (p <0.001), age (p <0.001), overweight (p <0.001), physical activity (p = 0.010), smoking (p = 0.031) and a history of diabetes mellitus (p <0.001) when adjusted for pharmacotherapy, only sex (p <0.001), age (p <0.001), overweight (p <0.001) and physical activity (p = 0.001), remained statistically significant. Conclusions: The new criteria increase the percentage of the patient that now will be classified as hypertension. This should be accompanied by effective politics in education, surveillance and adequate treatment of the health care system. Introduction: The American Heart Association/American College of Cardiology has published In 2017 new guidelines for hypertension. These guidelines change the criteria to classify patients with hypertension. There has not been yet a study that analyzes the consequences of these changes in developing countries. The objective of our study was to characterize changes in the classification of hypertension with the new guidelines among Peruvian patients and to determine the factors associated with being newly-diagnosed hypertensive. Methods: An analytical cross-sectional investigation was carried out, which was based on the secondary analysis of the data of hypertension. We compare certain variable including using antihypertensive medication, region, and other sociodemographic characteristics. We performed a descriptive analysis of the variables shown as frequency and percentage. P values that were less than 0.05 were considered statistically significant, it were obtained using a multivariate analysis. Results: Of the 5615 patients in this cohort, with the old criteria, 4915 (87.5%) did not have the diagnosis of hypertension; however, with the new criteria, 1,415 (25%) will be diagnosed with hypertension with the new criteria. 467 (9%) of patients who were not taking medications and 85 (32%) of patients who were taking medications will switch from having high-normal blood pressure to grade 1 hypertension, with the new guideline. The recent diagnosis of hypertension was associated with sex (p <0.001), age (p <0.001), overweight (p <0.001), physical activity (p = 0.010), smoking (p = 0.031) and a history of diabetes mellitus (p <0.001) when adjusted for pharmacotherapy, only sex (p <0.001), age (p <0.001), overweight (p <0.001) and physical activity (p = 0.001), remained statistically significant. Conclusions: The new criteria increase the percentage of the patient that now will be classified as hypertension. This should be accompanied by effective politics in education, surveillance and adequate treatment of the health care system.

This statistic shows the percentage of persons with hypertension in the U.S. in selected periods between 1988 and 2018. In the period 1988-1994, 49.4 percent of all males 20 years of age and over in the U.S. had hypertension.

Prevalence of measured cardiometabolic risk factors in the OPREVENT2 baseline sample.

BackgroundCardiovascular disease (CVD) morbidity and mortality is increasing in Africa, largely due to undiagnosed and untreated hypertension. Approaches that leverage existing primary health systems could improve hypertension treatment and reduce CVD, but cost-effectiveness is unknown. We evaluated the cost-effectiveness of population-level hypertension screening and implementation of chronic care clinics across eastern, southern, central, and western Africa.Methods and findingsWe conducted a modeling study to simulate hypertension and CVD across 3,000 scenarios representing a range of settings across eastern, southern, central, and western Africa. We evaluated 2 policies compared to current hypertension treatment: (1) expansion of HIV primary care clinics into chronic care clinics that provide hypertension treatment for all persons regardless of HIV status (chronic care clinic or CCC policy); and (2) CCC plus population-level hypertension screening of adults ≥40 years of age by community health workers (CHW policy). For our primary analysis, we used a cost-effectiveness threshold of US $500 per disability-adjusted life-year (DALY) averted, a 3% annual discount rate, and a 50-year time horizon. A strategy was considered cost-effective if it led to the lowest net DALYs, which is a measure of DALY burden that takes account of the DALY implications of the cost for a given cost-effectiveness threshold.Among adults 45 to 64 years, CCC implementation would improve population-level hypertension control (the proportion of people with hypertension whose blood pressure is controlled) from mean 4% (90% range 1% to 7%) to 14% (6% to 26%); additional CHW screening would improve control to 44% (35% to 54%). Among all adults, CCC implementation would reduce ischemic heart disease (IHD) incidence by 10% (3% to 17%), strokes by 13% (5% to 23%), and CVD mortality by 9% (3% to 15%). CCC plus CHW screening would reduce IHD by 28% (19% to 36%), strokes by 36% (25% to 47%), and CVD mortality by 25% (17% to 34%). CHW screening was cost-effective in 62% of scenarios, CCC in 31%, and neither policy was cost-effective in 7% of scenarios. Pooling across setting-scenarios, incremental cost-effectiveness ratios were $69/DALY averted for CCC and $389/DALY averted adding CHW screening to CCC.ConclusionsLeveraging existing healthcare infrastructure to implement population-level hypertension screening by CHWs and hypertension treatment through integrated chronic care clinics is expected to reduce CVD morbidity and mortality and is likely to be cost-effective in most settings across Africa.

This statistic shows hypertension and high blood pressure in the U.S. in selected periods between 1988 and 2016. In the period 2017 to 2018, some **** percent of all persons 20 years of age and over had hypertension.

The Health Survey for England series was designed to monitor trends in the nation's health, to estimate the proportion of people in England who have specified health conditions, and to estimate the prevalence of risk factors associated with these conditions. The surveys provide regular information that cannot be obtained from other sources on a range of aspects concerning the public's health. The surveys have been carried out since 1994 by the Joint Health Surveys Unit of NatCen Social Research and the Research Department of Epidemiology and Public Health at UCL. Each survey in the series includes core questions and measurements (such as blood pressure, height and weight, and analysis of blood and saliva samples), as well as modules of questions on topics that vary from year to year. New topics this year include hearing and mental health. The achieved sample for the 2014 survey was 8,077 adults (aged 16 and over) and 2,003 children (aged 0-15). This year tables are in excel spreadsheets and the way the findings are presented in the report and summary has changed. We would very much like to hear readers' views about these changes. Please tell us via the short reader survey at the bottom of this page in Related links. Please note this release was updated on 15 January 2016 to add chapter 2 - Mental Health Problems and chapter 3 - Attitudes towards Mental Illness and their associated excel tables and to update the Summary of Key Findings.

United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data was reported at 6.900 % in 2012. This records an increase from the previous number of 6.400 % for 2009. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data is updated yearly, averaging 6.900 % from Dec 1991 (Median) to 2012, with 6 observations. The data reached an all-time high of 8.700 % in 2005 and a record low of 5.100 % in 1991. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of overweight, female, is the percentage of girls under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; World Health Organization, Global Database on Child Growth and Malnutrition. Country-level data are unadjusted data from national surveys, and thus may not be comparable across countries.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

From 2017 to March 2020, the prevalence of hypertension among adult men in the United States with a family income more than 130% through 350% the federal poverty level was nearly 52 percent. This statistic shows the age-adjusted prevalence of hypertension among adults 18 years and older in the United States from 2017 to March 2020, by gender and family income relative to federal poverty level.

From 2017 to March 2020, a total of 47 percent of non-Hispanic white males in the United States suffered from hypertension. This statistic shows the prevalence of hypertension among adults in the U.S. from 2017 to March 2020, by gender and race/ethnicity.

a. The list of 862 ODs approved in the US between 1 January 1983 and 17 April 2020, inclusive, obtained from FDAOD. b. The list of the 862 ODs’ 552 unique trade names, and their break up into (i) 413 with single approvals, (ii) 139 with multiple approvals, and (iii) 40 cases with trade names unavailable. c. Of the 413 single approval trade names, 123 had a single mention in the Orange Book, and 290 either did not have any mention in the Orange Book or had multiple mentions in it. d. Of the 123 ODs with a single occurrence in the Orange Book, 72 were approved after 31 Dec 2008. e. Of the 72 ODs approved after 31 Dec 2008, 63 had publicly available FDA documents such as the Medical Review. f. The list of 63 ODs, with their year of marketing approval and the FDA document consulted for this study. g. From 2009–2020, per year (i) the number of ODs in this study, (ii) the percentage of ODs, out of 63 (iii) the percentage, in 3-year segments. (XLS)

The age-standardized prevalence of current antihypertensive medication use among U.S. adults aged between 18 and 44 years old was 42.5 percent in 2021. The statistic illustrates the percentage of U.S. adults with hypertension who were currently using antihypertensive medication from 2017 to 2021, by age.

During 2017-2019 the prevalence of any kind of hypertensive disorder during pregnancy was higher for hospitals in the South, with a rate of 15.9 percent. There the majority of pregnant patients having HDP suffered from pregnancy-associated hypertension with a rate of 12.6 percent. This graph shows the prevalence of U.S. women suffering from hypertensive disorders in pregnancy, by hospital region.

Roughly 40 percent of those diagnosed with multiple sclerosis in the U.S. also suffered from hypertension in 2017. The statistic shows rates of leading health conditions impacting those with multiple sclerosis compared to the overall population in the U.S. in 2017.